Global Surgical Site Infection Control Market Forecast 2024-2032

The global surgical site infection control market is expected to record a CAGR of 4.50% during the forecast period, 2024-2032. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The market study has also analyzed the impact of COVID-19 on the surgical site infection control market qualitatively as well as quantitatively.

Surgical site infection control refers to the comprehensive measures and protocols implemented before, during, and after surgical procedures to minimize the risk of infections at the incision site. It involves meticulous adherence to sterile techniques, proper preoperative skin preparation, effective antimicrobial prophylaxis, meticulous wound closure, and postoperative surveillance. These strategies aim to reduce the incidence of infections, promote patient safety, and enhance surgical outcomes.

MARKET INSIGHTS

Key enablers of the global surgical site infection control market growth:

Surge in geriatric population

The global landscape of healthcare is undergoing a significant transformation driven by demographic shifts, particularly the rapid increase in the geriatric population. As per the World Health Organization (WHO), by 2030, approximately one-sixth of the world's population is projected to be aged 60 years or older, rising from 1 billion in 2020 to 1.4 billion.

By 2050, this demographic is expected to double, reaching 2.1 billion individuals. This shift is profoundly impacting various facets of healthcare, including the prevalence of surgical procedures and associated risks such as surgical site infections (SSIs).

The vulnerability of the elderly population to infections is exacerbated by weakened immune systems and underlying health conditions. This underscores the critical importance of robust surgical site infection control measures to mitigate infection risks among older patients.

Healthcare providers are increasingly focusing on advanced technologies and protocols tailored to address the specific challenges posed by aging populations. As the geriatric demographic continues to expand globally, the demand for effective infection prevention and control in surgical environments is set to rise.

Increased incidence of hospital-acquired infections
Implementation of regulatory guidelines for the prevention of hospital-acquired infections

Key growth restraining factors of the global surgical site infection control market:

Lack of awareness with regard to hospital-acquired infections

Despite the significant impact of hospital-acquired infections (HAIs) on patient outcomes and healthcare costs, there remains a lack of awareness among both healthcare providers and patients regarding the risks and consequences of HAIs, including surgical site infections (SSIs).

This lack of awareness may lead to inadequate implementation of infection prevention measures, delayed diagnosis and treatment of SSIs, and overall suboptimal management of infection control protocols, thereby posing a challenge for the surgical site infection control market in effectively addressing and mitigating the risk of SSIs.

Surging medical waste due to the use of medical disposable items
Rising use of outpatient treatments

Surgical Site Infection Control Market | Top Trends

The rising rate of surgical procedures is driving the demand for innovative solutions in the surgical site infection control market, as the increased volume of surgeries heightens the importance of infection prevention measures.

Minimally invasive surgeries (MIS) and outpatient procedures are expanding due to their benefits, such as reduced recovery times, lower costs, and decreased risk of complications. This shift towards less invasive techniques and outpatient settings has driven the demand for effective infection control products and protocols.

Advancements in technology for preventing surgical site infections are revolutionizing the landscape of infection control, offering promising solutions such as advanced antimicrobial coatings, smart monitoring systems, and novel sterilization techniques to enhance patient safety and reduce the incidence of infections in surgical settings.

SEGMENTATION ANALYSIS

Market Segmentation - Procedure, Type of infection, End-User, and Product -

Market by Procedure:

Laparoscopy

Laparoscopic procedures, characterized by small incisions and minimally invasive techniques, have become increasingly common across various surgical specialties.

The market for surgical site infection control in laparoscopy focuses on specialized infection prevention measures tailored to the unique challenges of minimally invasive surgery, including sterilization of laparoscopic instruments, use of antimicrobial coatings on trocars and ports, and maintenance of aseptic techniques during laparoscopic procedures to minimize the risk of infections.

Orthopedic surgery
Cardiovascular
Obstetrics and Gynecology
Wound Closure
Plastic & Reconstructive Surgery
Thoracic Surgery
Microvascular
Urology
Neurosurgery
Other Procedures

Market by Type of Infection:

Superficial Incisional SSI

Superficial incisional surgical site infections (SSIs) are characterized by infections that involve only the skin and subcutaneous tissue at the surgical site.

While typically less severe compared to deep incisional or organ/space SSIs, they can still lead to complications such as delayed wound healing, prolonged hospital stays, and increased healthcare costs.

The market for superficial incisional SSI control encompasses a range of preventive measures and products aimed at reducing the risk of infection at the superficial layers of the surgical incision, including antiseptic solutions, antimicrobial dressings, and adhesive barriers.

Deep Incisional SSI
Organ or Space SSI

Market by End-User:

Hospitals
Ambulatory Surgical Centers

Market by Product:

Disinfectants

Skin Disinfectants

Hand Disinfectants

Manual Reprocessors Solutions
Surgical Drapes
Surgical Gloves
Skin Preparation Solutions
Surgical Irrigation
Surgical Scrubs
Hair Clippers
Medical Nonwovens
Other Products

REGIONAL ANALYSIS

Geographical Study based on Four Major Regions:

North America: The United States and Canada

North America, particularly the United States, witnesses a high volume of surgical procedures annually, leading to a greater demand for SSIC solutions.

The region also boasts some of the most advanced healthcare facilities globally, equipped with modern technologies and resources to implement effective infection control protocols.

Moreover, North America hosts a vibrant research and development (R&D) ecosystem dedicated to SSIC, leading to innovations in prevention, diagnosis, and treatment. This focus on innovation fosters the development of novel SSIC technologies and products, further propelling the market's growth.

Europe: The United Kingdom, Germany, France, Italy, Spain, Poland, Belgium and Rest of Europe
Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
Rest of World: Latin America, the Middle East & Africa

COMPETITIVE INSIGHTS

The major players in the global surgical site infection control market are:

3M Company
Becton, Dickinson and Company (BD)
Getinge AB
Johnson & Johnson
Stryker Corporation

Key strategies adopted by some of these companies:

In March 2022, Invenio unveiled the V90 surgical gown series, introducing a new range of surgical gowns.
In September 2022, STERIS inaugurated a medical device testing facility in Leipzig, Germany. This state-of-the-art facility expands the company's capabilities in medical device manufacturing, offering additional packaging and microbiological testing services.

We Offer 10% Free Customization and 3 Months Analyst Support

Frequently Asked Questions (FAQs):

What are the primary methods for managing surgical site infections?

A: Surgical site infection management involves a combination of strategies such as strict adherence to aseptic techniques, pre-operative antimicrobial prophylaxis, post-operative wound care, and surveillance to detect infections early.

How are surgical site wound infections categorized?

A: Surgical site wound infections are categorized based on the depth of infection into superficial incisional infections, deep incisional infections, and organ/space infections.

Product Code: 96046

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. HIGH EMPHASIS ON ENVIRONMENTAL HYGIENE BOOSTS THE SSI CONTROL MARKET
- 2.5.2. DISPOSABLE AND SINGLE-USE PRODUCTS ARE SHAPING THE SURGICAL INFECTION CONTROL LANDSCAPE

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGE IN GERIATRIC POPULATION
- 3.1.2. INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
- 3.1.3. IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL-ACQUIRED INFECTIONS
3.2. KEY RESTRAINTS
- 3.2.1. LACK OF AWARENESS ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS
- 3.2.2. SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS
- 3.2.3. RISING USE OF OUTPATIENT TREATMENTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. RISING RATE OF SURGICAL PROCEDURES
- 4.1.2. EXPANSION OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
- 4.1.3. ADVANCEMENTS IN TECHNOLOGY FOR PREVENTING SURGICAL SITE INFECTIONS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTIONS
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
- 4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
- 4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
- 4.3.4. GROWTH PROSPECT MAPPING FOR SAUDI ARABIA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY PROCEDURE

5.1. LAPAROSCOPY
5.2. ORTHOPEDIC SURGERY
5.3. CARDIOVASCULAR
5.4. OBSTETRICS AND GYNECOLOGY
5.5. WOUND CLOSURE
5.6. PLASTIC & RECONSTRUCTIVE SURGERY
5.7. THORACIC SURGERY
5.8. MICROVASCULAR
5.9. UROLOGY
5.10. NEUROSURGERY
5.11. OTHER PROCEDURES

6. MARKET BY TYPE OF INFECTION

6.1. SUPERFICIAL INCISIONAL SSI
6.2. DEEP INCISIONAL SSI
6.3. ORGAN OR SPACE SSI

7. MARKET BY END-USER

7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS

8. MARKET BY PRODUCT

8.1. DISINFECTANTS
- 8.1.1. SKIN DISINFECTANTS
- 8.1.2. HAND DISINFECTANTS
8.2. MANUAL REPROCESSORS SOLUTIONS
8.3. SURGICAL DRAPES
8.4. SURGICAL GLOVES
8.5. SKIN PREPARATION SOLUTIONS
8.6. SURGICAL IRRIGATION
8.7. SURGICAL SCRUBS
8.8. HAIR CLIPPERS
8.9. MEDICAL NONWOVENS
8.10. OTHER PRODUCTS

9. GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET DRIVERS
- 9.1.3. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET CHALLENGES
- 9.1.4. KEY PLAYERS IN NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET
- 9.1.5. COUNTRY ANALYSIS
  - 9.1.5.1. UNITED STATES
  - 9.1.5.1.1. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.1.5.2. CANADA
  - 9.1.5.2.1. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
9.2. EUROPE
- 9.2.1. MARKET SIZE & ESTIMATES
- 9.2.2. EUROPE SURGICAL SITE INFECTION CONTROL MARKET DRIVERS
- 9.2.3. EUROPE SURGICAL SITE INFECTION CONTROL MARKET CHALLENGES
- 9.2.4. KEY PLAYERS IN EUROPE SURGICAL SITE INFECTION CONTROL MARKET
- 9.2.5. COUNTRY ANALYSIS
  - 9.2.5.1. UNITED KINGDOM
  - 9.2.5.1.1. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.2. GERMANY
  - 9.2.5.2.1. GERMANY SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.3. FRANCE
  - 9.2.5.3.1. FRANCE SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.4. ITALY
  - 9.2.5.4.1. ITALY SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.5. SPAIN
  - 9.2.5.5.1. SPAIN SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.6. POLAND
  - 9.2.5.6.1. POLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.7. BELGIUM
  - 9.2.5.7.1. BELGIUM SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.2.5.8. REST OF EUROPE
  - 9.2.5.8.1. REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
9.3. ASIA-PACIFIC
- 9.3.1. MARKET SIZE & ESTIMATES
- 9.3.2. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET DRIVERS
- 9.3.3. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET CHALLENGES
- 9.3.4. KEY PLAYERS IN ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET
- 9.3.5. COUNTRY ANALYSIS
  - 9.3.5.1. CHINA
  - 9.3.5.1.1. CHINA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.2. JAPAN
  - 9.3.5.2.1. JAPAN SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.3. INDIA
  - 9.3.5.3.1. INDIA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.4. SOUTH KOREA
  - 9.3.5.4.1. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.5. INDONESIA
  - 9.3.5.5.1. INDONESIA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.6. THAILAND
  - 9.3.5.6.1. THAILAND SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.7. VIETNAM
  - 9.3.5.7.1. VIETNAM SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.8. AUSTRALIA & NEW ZEALAND
  - 9.3.5.8.1. AUSTRALIA & NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.3.5.9. REST OF ASIA-PACIFIC
  - 9.3.5.9.1. REST OF ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
9.4. REST OF WORLD
- 9.4.1. MARKET SIZE & ESTIMATES
- 9.4.2. REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET DRIVERS
- 9.4.3. REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET CHALLENGES
- 9.4.4. KEY PLAYERS IN REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET
- 9.4.5. REGIONAL ANALYSIS
  - 9.4.5.1. LATIN AMERICA
  - 9.4.5.1.1. LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
  - 9.4.5.2. MIDDLE EAST & AFRICA
  - 9.4.5.2.1. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. MERGERS & ACQUISITIONS
- 10.1.2. PARTNERSHIPS & AGREEMENTS
- 10.1.3. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
- 10.2.1. 3M COMPANY
  - 10.2.1.1. COMPANY OVERVIEW
  - 10.2.1.2. PRODUCTS
  - 10.2.1.3. STRENGTHS & CHALLENGES
- 10.2.2. AMERICAN POLYFILM
  - 10.2.2.1. COMPANY OVERVIEW
  - 10.2.2.2. PRODUCTS
  - 10.2.2.3. STRENGTHS & CHALLENGES
- 10.2.3. ANSELL LTD
  - 10.2.3.1. COMPANY OVERVIEW
  - 10.2.3.2. PRODUCTS
  - 10.2.3.3. STRENGTHS & CHALLENGES
- 10.2.4. BECTON, DICKINSON AND COMPANY (BD)
  - 10.2.4.1. COMPANY OVERVIEW
  - 10.2.4.2. PRODUCTS
  - 10.2.4.3. STRENGTHS & CHALLENGES
- 10.2.5. BELIMED AG
  - 10.2.5.1. COMPANY OVERVIEW
  - 10.2.5.2. PRODUCTS
  - 10.2.5.3. STRENGTHS & CHALLENGES
- 10.2.6. BIOMERIEUX SA
  - 10.2.6.1. COMPANY OVERVIEW
  - 10.2.6.2. PRODUCTS
  - 10.2.6.3. STRENGTHS & CHALLENGES
- 10.2.7. GAMA HEALTHCARE
  - 10.2.7.1. COMPANY OVERVIEW
  - 10.2.7.2. PRODUCTS
  - 10.2.7.3. STRENGTHS & CHALLENGES
- 10.2.8. GETINGE AB
  - 10.2.8.1. COMPANY OVERVIEW
  - 10.2.8.2. PRODUCTS
  - 10.2.8.3. STRENGTHS & CHALLENGES
- 10.2.9. JOHNSON & JOHNSON
  - 10.2.9.1. COMPANY OVERVIEW
  - 10.2.9.2. PRODUCTS
  - 10.2.9.3. STRENGTHS & CHALLENGES
- 10.2.10. KIMBERLY-CLARK
  - 10.2.10.1. COMPANY OVERVIEW
  - 10.2.10.2. PRODUCTS
  - 10.2.10.3. STRENGTHS & CHALLENGES
- 10.2.11. SOTERA HEALTH LLC
  - 10.2.11.1. COMPANY OVERVIEW
  - 10.2.11.2. PRODUCTS
  - 10.2.11.3. STRENGTHS & CHALLENGES
- 10.2.12. STERIS CORPORATION
  - 10.2.12.1. COMPANY OVERVIEW
  - 10.2.12.2. PRODUCTS
  - 10.2.12.3. STRENGTHS & CHALLENGES
- 10.2.13. STRYKER CORPORATION
  - 10.2.13.1. COMPANY OVERVIEW
  - 10.2.13.2. PRODUCTS
  - 10.2.13.3. STRENGTHS & CHALLENGES

Product Code: 96046

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - SURGICAL SITE INFECTION CONTROL
TABLE 2: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GLOBAL LAPAROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL LAPAROSCOPY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL CARDIOVASCULAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL CARDIOVASCULAR MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL OBSTETRICS AND GYNECOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL OBSTETRICS AND GYNECOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL WOUND CLOSURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL WOUND CLOSURE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL PLASTIC & RECONSTRUCTIVE SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL PLASTIC & RECONSTRUCTIVE SURGERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GLOBAL THORACIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL THORACIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: GLOBAL MICROVASCULAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL MICROVASCULAR MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 20: GLOBAL UROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL UROLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 22: GLOBAL NEUROSURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL NEUROSURGERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 24: GLOBAL OTHER PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL OTHER PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 26: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 28: GLOBAL SUPERFICIAL INCISIONAL SSI MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL SUPERFICIAL INCISIONAL SSI MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 30: GLOBAL DEEP INCISIONAL SSI MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL DEEP INCISIONAL SSI MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 32: GLOBAL ORGAN OR SPACE SSI MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: GLOBAL ORGAN OR SPACE SSI MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 34: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 35: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 38: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 40: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 42: GLOBAL DISINFECTANTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 43: GLOBAL DISINFECTANTS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 44: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 46: GLOBAL SKIN DISINFECTANTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 47: GLOBAL SKIN DISINFECTANTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 48: GLOBAL HAND DISINFECTANTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 49: GLOBAL HAND DISINFECTANTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 50: GLOBAL MANUAL REPROCESSORS SOLUTIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 51: GLOBAL MANUAL REPROCESSORS SOLUTIONS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 52: GLOBAL SURGICAL DRAPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 53: GLOBAL SURGICAL DRAPES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 54: GLOBAL SURGICAL GLOVES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 55: GLOBAL SURGICAL GLOVES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 56: GLOBAL SKIN PREPARATION SOLUTIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 57: GLOBAL SKIN PREPARATION SOLUTIONS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 58: GLOBAL SURGICAL IRRIGATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 59: GLOBAL SURGICAL IRRIGATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 60: GLOBAL SURGICAL SCRUBS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 61: GLOBAL SURGICAL SCRUBS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 62: GLOBAL HAIR CLIPPERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 63: GLOBAL HAIR CLIPPERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 64: GLOBAL MEDICAL NONWOVENS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 65: GLOBAL MEDICAL NONWOVENS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 66: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 67: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 68: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 69: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 70: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 71: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 72: KEY PLAYERS OPERATING IN NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET
TABLE 73: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 74: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 75: KEY PLAYERS OPERATING IN EUROPE SURGICAL SITE INFECTION CONTROL MARKET
TABLE 76: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 77: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 78: KEY PLAYERS OPERATING IN ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET
TABLE 79: REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 80: REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 81: KEY PLAYERS OPERATING IN REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET
TABLE 82: LIST OF MERGERS & ACQUISITIONS
TABLE 83: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 84: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY
FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 6: GROWTH PROSPECT MAPPING FOR SAUDI ARABIA
FIGURE 7: MARKET MATURITY ANALYSIS
FIGURE 8: MARKET CONCENTRATION ANALYSIS
FIGURE 9: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2023
FIGURE 10: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 20: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY TYPE OF INFECTION, IN 2023
FIGURE 22: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 23: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 24: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 25: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 26: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 27: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 28: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 29: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 30: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY DISINFECTANTS, IN 2023
FIGURE 31: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 32: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 33: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 34: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 35: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 36: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 37: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 38: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 39: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 40: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 41: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 42: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 43: UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 44: CANADA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 45: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 46: UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 47: GERMANY SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 48: FRANCE SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 49: ITALY SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 50: SPAIN SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 51: POLAND SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 52: BELGIUM SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 53: REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 54: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 55: CHINA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 56: JAPAN SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 57: INDIA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 58: SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 59: INDONESIA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 60: THAILAND SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 61: VIETNAM SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 62: AUSTRALIA & NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 63: REST OF ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 64: REST OF WORLD SURGICAL SITE INFECTION CONTROL MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 65: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 66: MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)